Reuters logo
BRIEF-Shandong Buchang Pharmaceuticals unit receives approval for drug clinical trial
September 13, 2017 / 4:12 AM / 8 days ago

BRIEF-Shandong Buchang Pharmaceuticals unit receives approval for drug clinical trial

Sept 13(Reuters) - Shandong Buchang Pharmaceuticals Co Ltd

* Says its Shaanxi-based wholly owned pharmaceutical unit received approval for drug clinical trial for a kind of granule, from China Food and Drug Administration

* Says the granule is mainly used for treatment of cardiovascular disease and diabetes

Source text in Chinese: goo.gl/ViWYYr

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below